Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Teva Pharmaceuticals USA Recalls Single Lot of Nabumetone Tablets USP, 750 mg
Teva Pharmaceuticals has recalled a single lot of Nabumetone Tablets USP, 750 mg. Lot number 05N243 is being recalled because this lot did not meet the Food and Drug Adminstration’s (FDA) standards for testing and quality during manufacturing. Nabumetone is used in the treatment of pain. This recall alert only applies to the single lot of the generic Nabumetone Tablets USP, 750 mg made by Teva Pharmaceuticals. No other Nabumetone products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm253935.htm
Learn More

Pentrexyl Forte Natural Recalled Due to Misleading Packaging
Phoenix Import & Distribution LLC and FDA notified the public of a recall for Pentrexyl Forte Natural because the packaging is believed to be misleading, causing it to be confused with an antibiotic.  Pentrexyl Forte Natural is a Dietary Supplement only and does not contain antibiotics. Use of the product by people who are sick could delay treatment for serious illnesses. The recalled product is packaged in a green and white box, containing 30 red and white capsules. The product was sold through retail stores in Texas. For more information, please visit: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm256407.htm
Learn More

Receive Safety Alerts & Recalls by email or text message.

Register

Date Published Title Drug Source
2011-06-01 Teva Pharmaceuticals USA Recalls Single Lot of Nabumetone Tablets USP, 750 mg Nabumetone FDA
2011-06-01 Pentrexyl Forte Natural Recalled Due to Misleading Packaging Ampicillin FDA
2011-05-31 FDA to review studies showing higher blood clot risk from drospirenone Drospirenone with Ethinyl Estradiol FDA
2011-05-27 Teva Pharmaceuticals USA. Recalls Single Lot of Fexofenadine Hydrochloride Tablets USP, 180 mg Fexofenadine FDA
2011-05-26 FDA Conducting a Safety Review of Revlimid and Risk of Developing Another Primary Cancer Lenalidomide FDA
2011-05-26 FDA Issues Statement on the AIM-HIGH Trial Niacin FDA
2011-05-26 Regrowth LLC Recalls Several Lots of Retinoic Acid, Minoxidil, and Spironolactone Topical Solution Tretinoin FDA
2011-05-26 Pfizer Pharmaceuticals LLC. Recalls Single Lot of Aldactone (spironoloactone) tablets USP 50 mg Spironolactone FDA
2011-05-20 Coloplast Manufacturing US Recalls Select Lots of Critic-Aid Skin Paste 2.5 oz/71g Petrolatum and Zinc Oxide FDA
2011-05-20 Novartis Pharmaceuticals Corp. Recalls Single Lot of Valturna (aliskiren and valsartan) Tablets 300 mg/320 mg Aliskiren and Valsartan FDA
2011-05-20 Teva Pharmaceuticals Recalls Single Lot of Metformin Hydrochloride Tablets, USP 500 mg Metformin FDA
2011-05-20 Teva Pharmaceuticals Recalls Several Lots of Simvastatin Tablets USP, 20 mg and 80 mg Simvastatin FDA
2011-05-19 Avandia, Avandamet, and Avandaryl Soon to Be Available Only Through Avandia-Rosiglitazone Medicines Access Program Glimepiride and Rosiglitazone FDA
2011-05-11 Multi-Mex Distributor Inc. Announces Recall of Dietary Supplements Amoxicillin FDA
2011-05-06 FDA Provides Guidance for Dispensing Devices and Drugmakers Remove OTC Infant Acetaminophen Drops FDA
2011-05-06 Benefits of Bisphosphonates Continue to Outweigh Risks Ibandronate Sodium MediGuard CRT
2011-05-02 Bristol-Myers Squibb Recalls Coumadin 5 mg Tablets Warfarin Manufacturer
2011-05-02 Novartis Pharmaceuticals Recalls Single Lot of Foradil Aerolizer (formoterol fumerate inhalation powder), 12 mcg Formoterol FDA
2011-05-02 Aurobindo Pharmaceuticals Recalls Several Lots of Mirtazapine Tablets, 45 mg Mirtazapine FDA
2011-05-02 Abbott Laboratories Recalls Select Lots of Humira (adalimumab) Pen, 40 mg/0.8mL Adalimumab FDA